FBInvestor
Stocks / Immix Biopharma Inc
Institutional Ownership

Immix Biopharma Inc

CUSIP 45258H106COMIMMXQ1 2026

13D / 13G Filings
9
Schedule 13D/13G on record
Beneficial Filers
7
Distinct reporting persons
Largest Stake
20.0%
Max % of class reported
Institutional Holders
74
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

9 filings · latest Feb 17, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 17, 2026Janus Henderson Group PLC13G7.4%3.92MSEC
2Feb 17, 2026Saturn V Capital Management LP13G7.0%3.69MSEC
3Jan 29, 2025Orin Hirschman13G/ASEC
4Feb 7, 2024Hirschman Orin13G5.8%1.46MSEC
5Aug 30, 2023Gkcc, LLC13D20.0%3.26MSEC
6Mar 2, 2022Murchinson Ltd.13G/ASEC
7Feb 11, 2022Altium Capital Management LP13G/A1.6%122.4KSEC
8Feb 9, 2022Murchinson Ltd.13G5.3%695.6KSEC
9Dec 28, 2021Altium Capital Management LP13G8.2%674.4KSEC

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →